A BiOBr / BiOIO3 photocatalyst and its preparation method and application

By preparing a Z-shaped heterojunction of BiOBr/BiOIO3 photocatalyst, the problem of low photoresponse rate of BiOBr and BiOIO3 was solved, achieving efficient photocatalytic degradation under visible and near-infrared light, which is suitable for purifying antibiotics and bisphenol A in water.

CN115869972BActive Publication Date: 2024-11-05SHAANXI UNIV OF SCI & TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211457617.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-11-21
Publication Date
2024-11-05
Estimated Expiration
2042-11-21

AI Technical Summary

Technical Problem

Existing BiOBr photocatalysts have limited photoresponse rate, fast carrier recombination, and poor charge separation efficiency. BiOIO3 has a large band gap and only responds to ultraviolet light, which limits its application. Existing BiOIO3 photocatalysts have insufficient response to visible and near-infrared light.

Method used

By preparing BiOBr/BiOIO3 photocatalysts and forming Z-shaped heterojunctions, the built-in electric field and ion defect pairs of the BiOBr and BiOIO3 heterojunctions are utilized to enhance the separation and migration rates of photogenerated electrons and holes, thereby improving the photocatalytic activity in visible and near-infrared light.

Benefits of technology

The photocatalytic activity of BiOBr/BiOIO3 photocatalyst under visible and near-infrared light was enhanced, improving the degradation efficiency of antibiotics and bisphenol A and achieving more efficient solar energy utilization.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0003953723130000011
    Figure HDA0003953723130000011
  • Figure HDA0003953723130000012
    Figure HDA0003953723130000012
  • Figure HDA0003953723130000021
    Figure HDA0003953723130000021
Patent Text Reader

Abstract

The present invention discloses a BiOBr / BiOIO3 photocatalyst and a preparation method and application thereof. In the BiOBr / BiOIO3 photocatalyst, BiOBr and BiOIO3 coexist in two phases, and BiOBr and BiOIO3 form a Z-type heterojunction. The preparation method comprises the following steps: step 1: dissolving bismuth nitrate pentahydrate and sodium bromide in water to obtain a precursor solution A, subjecting the precursor solution A to a hydrothermal reaction, washing and drying the obtained solid product, and obtaining a nano-flower-shaped BiOBr powder; step 2: dispersing the nano-flower-shaped BiOBr powder and sodium iodate in water to obtain a precursor solution B; step 3: subjecting the precursor solution B to a hydrothermal reaction, washing and drying the obtained precipitate, and obtaining a BiOBr / BiOIO3 photocatalyst. The BiOBr / BiOIO3 photocatalyst improves the separation rate of photogenerated electrons and holes and the electron migration rate, and enhances the photocatalytic activity under visible light and near-infrared light.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of photocatalytic material preparation, and specifically relates to a BiOBr / BiOIO3 photocatalyst and a preparation method and application thereof. Background Art

[0002] Dyes and antibiotics, as a class of "emerging pollutants", have caused irreversible damage to water resources due to their difficulty in decomposition, and can cause diseases such as cancer after entering the human body. Semiconductor photocatalysis is a new type of environmentally friendly technology that can effectively use solar energy to degrade organic pollutants, so it has attracted the attention of researchers. At present, the research and development of photocatalysts for the degradation of organic pollutants has been widely used. However, most photocatalysts have low generation rates or high recombination rates of photogenerated carriers. Therefore, the design and development of efficient photocatalysts remains a hot topic.

[0003] The bottom of the conduction band of BiOBr is mainly composed of Bi 6p orbitals, and the top of the valence band is composed of O 2p and Br 4p orbitals. The bromide ion forms [Br2] 2- layer, Bi and O are connected by strong covalent bonds to form [Bi2O2] 2+ layer, in the crystal [Br2] 2- Layer and [Bi2O2] 2+ The layers are connected by van der Waals forces, arranged alternately, and form a tetragonal crystal structure along the

[001] direction. However, single BiOBr still faces serious problems such as limited photoresponse rate, rapid recombination of carriers and poor charge separation efficiency, resulting in low photocatalytic activity and limiting practical applications.

[0004] BiOIO3 has been studied as a new type of bismuth-based photocatalyst, which is composed of [Bi2O2] 2+ Layers and interlayers [IO3] - The anion-based layered topology has several advantages, including a non-centrosymmetric crystal structure, an internal electrostatic field induced by the layered structure, and a polarity that produces a polarization electric field.[IO3] - The presence of a photocatalytic group in the photocatalytic degradation of antibiotics is highly efficient. However, the relatively large band gap (~3 eV) means that it responds almost exclusively to ultraviolet light, which severely limits its application. Summary of the invention

[0005] In view of the problems existing in the prior art, the present invention provides a BiOBr / BiOIO3 photocatalyst and a preparation method and application thereof. The BiOBr / BiOIO3 photocatalyst improves the separation rate of photogenerated electrons and holes and the electron migration rate, and enhances the photocatalytic activity under visible light and near-infrared light.

[0006] The present invention is achieved through the following technical solutions:

[0007] A BiOBr / BiOIO3 photocatalyst, wherein BiOBr and BiOIO3 coexist in the BiOBr / BiOIO3 photocatalyst, and BiOBr and BiOIO3 form a Z-type heterojunction.

[0008] A method for preparing a BiOBr / BiOIO3 photocatalyst comprises the following steps:

[0009] Step 1: dissolving bismuth nitrate pentahydrate and sodium bromide in water to obtain a precursor solution A, subjecting the precursor solution A to a hydrothermal reaction, washing and drying the obtained solid product to obtain a nano-flower-shaped BiOBr powder;

[0010] Step 2: Dispersing nanoflower-shaped BiOBr powder and sodium iodate in water to obtain precursor solution B;

[0011] Step 3: The precursor solution B is subjected to a hydrothermal reaction, and the resulting precipitate is washed and dried to obtain a BiOBr / BiOIO3 photocatalyst.

[0012] Preferably, in step 1, the molar ratio of bismuth nitrate pentahydrate to sodium bromide is 1:1.

[0013] Preferably, in step 1, the temperature of the hydrothermal reaction is 160° C. and the time is 12 h.

[0014] Preferably, in step 2, the molar ratio of the nano-flower-shaped BiOBr powder to sodium iodate in the precursor solution B is (0.25-2): (0.125-1).

[0015] Preferably, in step 2, in the precursor solution B, the concentrations of BiOBr and NaIO3 are (0.00625-0.05) mol / L and (0.003125-0.0375) mol / L, respectively.

[0016] Preferably, in step 3, the temperature of the hydrothermal reaction is 140-200° C. and the time is 5-8 h.

[0017] The BiOBr / BiOIO3 photocatalyst is used for catalytic degradation of antibiotics or bisphenol A under light conditions.

[0018] Preferably, the antibiotic is tetracycline or ciprofloxacin.

[0019] Preferably, the lighting condition is infrared light irradiation, visible light irradiation or sunlight irradiation.

[0020] Compared with the prior art, the present invention has the following beneficial effects:

[0021] The present invention will contain Bi3+ / Bi +(3-x) Ion pairs of BiOBr and IO3 - / I3 - / I - The BiOBr / BiOIO3 heterojunction is obtained by combining the ion pairs of BiOIO3. 3+ / Bi +(3-x) Yes, resulting in a large number of bound free electrons in the BiOBr crystal. The work function of BiOBr (5.91 eV) is smaller than that of BiOIO3 (6.69 eV). When BiOBr and BiOIO3 are combined, the Fermi level (E f ), the bound free electrons in the BiOBr crystal will transfer to BiOIO3 until their E f Aligned at the same level, therefore, the Fermi level and band structure of BiOBr and BiOIO3 decrease and increase, respectively, forming an interfacial built-in electric field from BiOIO3 pointing to BiOBr, forming a BiOBr / BiOIO3 Z-type heterojunction photocatalyst, enhancing the redox potential energy of photogenerated electrons and holes, and enhancing the photocatalytic activity of the heterojunction under visible and near-infrared light.

[0022] The invention discloses a method for preparing a BiOBr / BiOIO3 photocatalyst. The method comprises dispersing nano-flower-shaped BiOBr powder and NaIO3 in deionized water and performing hydrothermal treatment to obtain a BiOBr / BiOIO3 Z-type heterojunction photocatalyst. The method adopts a hydrothermal method for preparation, which is simple to operate and has mild reaction conditions. The prepared photocatalyst has a good degradation effect on antibiotics under visible light and near-infrared light.

[0023] The BiOBr / BiOIO3 Z-type heterojunction photocatalyst of the present invention, under visible light, under the action of the built-in electric field of the interface, the electrons in the conduction band of BiOBr recombine with the holes in the valence band of BiOIO3, retaining the conduction band electrons with strong reducing ability of BiOIO3 and the holes in the valence band with strong oxidizing ability of BiOBr, degrading antibiotics and bisphenol A. Under near-infrared irradiation, IO3 in BiOIO3 - / I3 - / I - In a dynamic cycle, active species are formed. - , ·OH, 1 O2 reacts with antibiotics and bisphenol A. 3 + / Bi +(3-x) The bound electrons formed in BiOBr generate hot electrons under the excitation of infrared to form ·O2 - Participate in the degradation reaction. BiOBr / BiOIO3 heterojunction contains Bi3+ / Bi +(3-x) and io3 - / I3 - / I - Defect pairs, under near-infrared irradiation, electrons and holes can quickly migrate to the conduction band and valence band of BiOBr and BiOIO3 through the impurity energy level, and degrade antibiotics and bisphenol A according to the Z-type mechanism. BiOBr / BiOIO3 Z-type heterojunction photocatalyst has built-in interface electric field, LSPR effect of ion defect pairs and IO3 - / I3 - / I - Under the action of multiple active species formed by dynamic circulation, it has enhanced degradation efficiency for antibiotics and bisphenol A under visible light and near-infrared light, and has good application prospects in purifying water pollution. BRIEF DESCRIPTION OF THE DRAWINGS

[0024] Figure 1 1 is the XRD diagram of the BiOBr / BiOIO3 photocatalyst prepared in Comparative Example 1, Comparative Example 2 and Examples 1-4 of the present invention.

[0025] Figure 2 It is the Raman image of BiOBr / BiOIO3 photocatalyst prepared in Comparative Example 1, Comparative Example 2 and Example 2 of the present invention.

[0026] Figure 3 It is the XPS graph of BiOBr / BiOIO3 photocatalysts prepared in Comparative Example 1, Comparative Example 2 and Example 2 of the present invention.

[0027] Figure 4 It is a high-resolution O 1s XPS spectrum of the BiOBr / BiOIO3 photocatalyst prepared in Comparative Example 1, Comparative Example 2 and Example 2 of the present invention.

[0028] Figure 5 It is the high-resolution Bi 4f XPS spectrum of the BiOBr / BiOIO3 photocatalyst prepared in Comparative Example 1, Comparative Example 2 and Example 2 of the present invention.

[0029] Figure 6 It is the high-resolution I 3dXPS spectrum of the BiOBr / BiOIO3 photocatalyst prepared in Comparative Example 2 and Example 2 of the present invention.

[0030] Figure 7 It is the UV-visible diffuse reflectance spectra of the BiOBr / BiOIO3 photocatalysts prepared in Comparative Example 1, Comparative Example 2 and Examples 1-4 of the present invention.

[0031] Figure 8This is the removal curve of tetracycline under visible light by the BiOBr / BiOIO3 photocatalysts prepared in Comparative Example 1, Comparative Example 2 and Examples 1-4 of the present invention.

[0032] Fig. 9 It is the apparent rate constant of tetracycline degradation under visible light by the BiOBr / BiOIO3 catalysts prepared in Comparative Example 1, Comparative Example 2 and Examples 1-4 of the present invention.

[0033] Fig.10 This is the removal curve of tetracycline by the BiOBr / BiOIO3 photocatalyst prepared in Comparative Example 1, Comparative Example 2 and Examples 1-4 of the present invention under near-infrared light.

[0034] Fig.11 It is the apparent rate constant of tetracycline degradation under near-infrared light by the BiOBr / BiOIO3 catalysts prepared in Comparative Example 1, Comparative Example 2 and Examples 1-4 of the present invention.

[0035] Fig.12 This is a graph showing the degradation of bisphenol A and ciprofloxacin by the BiOBr / BiOIO3 photocatalyst prepared in Example 2 of the present invention under visible light and near-infrared light.

[0036] Fig.13 It is the band gap diagram of BiOBr and BiOIO3 photocatalysts prepared in Comparative Examples 1 and 2 of the present invention.

[0037] Fig.14 It is the XPS VB diagram of the BiOBr photocatalyst prepared in Comparative Example 1 of the present invention.

[0038] Fig.15 It is the XPS VB diagram of the BiOIO3 photocatalyst prepared in Comparative Example 2 of the present invention.

[0039] Fig.16 This is a detection diagram of active species of tetracycline degradation under visible light by the BiOBr / BiOIO3 catalyst prepared in Example 2 of the present invention.

[0040] Fig.17 It is a photocatalytic mechanism diagram of the BiOBr / BiOIO3 heterojunction photocatalyst prepared by the present invention. DETAILED DESCRIPTION

[0041] In order to further understand the present invention, the present invention is described below in conjunction with embodiments. These descriptions are only to further explain the features and advantages of the present invention and are not intended to limit the claims of the present invention.

[0042] In the BiOBr / BiOIO3 photocatalyst of the present invention, BiOBr and BiOIO3 coexist, and BiOBr and BiOIO3 form a Z-type BiOBr / BiOIO3 heterojunction, wherein BiOBr is a tetragonal phase structure with a space group of P4 / nmm(129), and BiOIO3 is an orthorhombic phase structure. The chemical formula of BiOIO3 is: BiOIO 1-x-y (I3) x I y , that is, part of IO3 - Restored to I3 - and I - The chemical formula of BiOBr / BiOIO3 can be written as BiOBr / BiOIO 1-x-y (I3) x I y .

[0043] The method for preparing the BiOBr / BiOIO3 photocatalyst of the present invention comprises the following steps:

[0044] Step 1: Dissolve Bi(NO3)3·5H2O and sodium bromide in water, and then stir until the solution is uniform to obtain precursor solution A. Hydrothermally react the precursor solution A at 160°C for 12 hours, wash, dry and grind the obtained solid product to obtain nano-flower-shaped BiOBr powder;

[0045] Step 2: Disperse the nano-flower spherical BiOBr powder and NaIO3 in water, and then stir to obtain precursor solution B;

[0046] Step 3: The precursor solution B is subjected to a hydrothermal reaction, and the precipitate is washed, dried and ground to obtain a BiOBr / BiOIO3 photocatalyst.

[0047] In step 1, the molar ratio of Bi(NO3)3·5H2O to sodium bromide is 1:1.

[0048] In step 2, the molar ratio of BiOBr to NaIO3 in the precursor solution B is (0.25-2): (0.125-1). The concentrations of BiOBr and NaIO3 are (0.00625-0.05) mol / L and (0.003125-0.0375) mol / L, respectively.

[0049] In step 3, the hydrothermal temperature is 140-200° C., the hydrothermal time is 5-8 hours, and the precursor solution B is washed with deionized water and anhydrous ethanol respectively after the hydrothermal reaction. The filter cake after hydrothermal washing is dried at 70° C. for 12 hours.

[0050] The BiOBr / BiOIO3 photocatalyst can degrade antibiotics and bisphenol A under visible light and near-infrared light, wherein the antibiotics are tetracycline or ciprofloxacin.

[0051] The specific embodiments are as follows.

[0052] Comparative Example 1

[0053] Step 1: Add 1 mmol of bismuth nitrate pentahydrate and 1 mmol of sodium bromide into 40 mL of deionized water and stir for 30 min to completely dissolve to obtain precursor solution A.

[0054] Step 2: Transfer the precursor solution A to a hydrothermal autoclave with a filling ratio of 80%. Raise the temperature of the hydrothermal autoclave from room temperature to 160°C in 1 hour, maintain the temperature at 160°C for 12 hours, and obtain a precipitate.

[0055] Step 3: The precipitate was washed three times with deionized water and anhydrous ethanol in sequence, and dried at 70° C. for 12 h to obtain a nanoflower-shaped BiOBr photocatalyst.

[0056] Comparative Example 2

[0057] Step 1: Add 1 mmol of bismuth nitrate pentahydrate and 1 mmol of sodium iodate into 40 mL of deionized water and stir for 30 min to completely dissolve to obtain precursor solution A.

[0058] Step 2: Transfer the precursor solution A to a hydrothermal autoclave with a filling ratio of 80%. Raise the temperature of the hydrothermal autoclave from room temperature to 160°C in 1 hour, maintain the temperature at 160°C for 6 hours, and obtain a precipitate.

[0059] Step 3: The precipitate was washed three times with deionized water and anhydrous ethanol respectively, and dried at 70°C for 12 h to obtain a BiOIO3 photocatalyst.

[0060] Example 1

[0061] Step 1: Add 1 mmol of bismuth nitrate pentahydrate and 1 mmol of sodium bromide into 40 mL of deionized water and stir for 30 min until the solution is uniform to obtain precursor solution A. Hydrothermally react the precursor solution A at 160 ° C for 12 h, with a filling rate of 80%. Finally, collect the precipitate in the reaction solution, wash it with deionized water and anhydrous ethanol for 3 times, dry it and grind it to obtain nano-flower spherical BiOBr powder;

[0062] Step 2: Disperse 1 mmol of nanoflower spherical BiOBr powder and 0.125 mmol of sodium iodate in 40 mL of deionized water, and then stir for 30 min to obtain precursor solution B;

[0063] Step 3: The precursor solution B was transferred to a hydrothermal reactor for hydrothermal reaction at 150°C for 6 hours with a filling rate of 80%. After the reaction was completed, the precipitate was washed 3 times with deionized water and anhydrous ethanol respectively, dried at 70°C for 12 hours and then ground to obtain BiOBr / BiOIO3 photocatalyst.

[0064] Example 2

[0065] Step 1: Dissolve 1 mmol of bismuth nitrate pentahydrate and 1 mmol of sodium bromide in 40 mL of deionized water, and then stir for 30 min until the solution is uniform to obtain precursor solution A. Hydrothermally react the precursor solution A at 160 ° C for 12 h, with a filling rate of 80%. Finally, collect the precipitate in the reaction solution in turn, wash it with deionized water and anhydrous ethanol for 3 times, dry it and grind it to obtain nano-flower spherical BiOBr powder;

[0066] Step 2: Disperse 1 mmol of nanoflower spherical BiOBr powder and 0.25 mmol of sodium iodate in 40 mL of deionized water, and then stir for 30 min to obtain precursor solution B;

[0067] Step 3: The precursor solution B was transferred to a hydrothermal reactor for hydrothermal reaction at 150°C for 6 hours with a filling rate of 80%. After the reaction was completed, the precipitate was washed 3 times with deionized water and anhydrous ethanol respectively, dried at 70°C for 12 hours and then ground to obtain BiOBr / BiOIO3 photocatalyst.

[0068] Example 3

[0069] Step 1: Dissolve 1 mmol of bismuth nitrate pentahydrate and 1 mmol of sodium bromide in 40 mL of deionized water, and then stir for 30 min until the solution is uniform to obtain precursor solution A. Hydrothermally react the precursor solution A at 160 ° C for 12 h, with a filling rate of 80%. Finally, collect the precipitate in the reaction solution in turn, wash it with deionized water and anhydrous ethanol for 3 times, dry it and grind it to obtain nano-flower spherical BiOBr powder;

[0070] Step 2: Disperse 1 mmol of nanoflower spherical BiOBr powder and 0.5 mmol of sodium iodate in 40 mL of deionized water, and then stir for 30 min to obtain precursor solution B;

[0071] Step 3: The precursor solution B was transferred to a hydrothermal reactor for hydrothermal reaction at 150°C for 6 hours with a filling rate of 80%. After the reaction was completed, the precipitate was washed 3 times with deionized water and anhydrous ethanol respectively, dried at 70°C for 12 hours and then ground to obtain BiOBr / BiOIO3 photocatalyst.

[0072] Example 4

[0073] Step 1: Dissolve 1 mmol of bismuth nitrate pentahydrate and 1 mmol of sodium bromide in 40 mL of deionized water, and then stir for 30 min until the solution is uniform to obtain precursor solution A. Hydrothermally react the precursor solution A at 160 ° C for 12 h, with a filling rate of 80%. Finally, collect the precipitate in the reaction solution in turn, wash it with deionized water and anhydrous ethanol for 3 times, dry it and grind it to obtain nano-flower spherical BiOBr powder;

[0074] Step 2: Disperse 1 mmol of nanoflower spherical BiOBr powder and 1 mmol of sodium iodate in 40 mL of deionized water, and then stir for 30 min to obtain precursor solution B;

[0075] Step 3: The precursor solution B was transferred to a hydrothermal reactor for hydrothermal reaction at 150°C for 6 hours with a filling rate of 80%. After the reaction was completed, the precipitate was washed 3 times with deionized water and anhydrous ethanol respectively, dried at 70°C for 12 hours and then ground to obtain BiOBr / BiOIO3 photocatalyst.

[0076] Example 5

[0077] Step 1: Dissolve 1 mmol of bismuth nitrate pentahydrate and 1 mmol of sodium bromide in 40 mL of deionized water, and then stir for 30 min until the solution is uniform to obtain precursor solution A. Hydrothermally react the precursor solution A at 160 ° C for 12 h, with a filling rate of 80%. Finally, collect the precipitate in the reaction solution in turn, wash it with deionized water and anhydrous ethanol for 3 times, dry it and grind it to obtain nano-flower spherical BiOBr powder;

[0078] Step 2: Disperse 0.25 mmol of nanoflower spherical BiOBr powder and 1 mmol of sodium iodate in 40 mL of deionized water, and then stir for 30 min to obtain precursor solution B;

[0079] Step 3: The precursor solution B was transferred to a hydrothermal reactor for hydrothermal reaction at 150°C for 6 hours with a filling rate of 80%. After the reaction was completed, the precipitate was washed 3 times with deionized water and anhydrous ethanol respectively, dried at 70°C for 12 hours and then ground to obtain BiOBr / BiOIO3 photocatalyst.

[0080] Example 6

[0081] Step 1: Dissolve 1 mmol of bismuth nitrate pentahydrate and 1 mmol of sodium bromide in 40 mL of deionized water, and then stir for 30 min until the solution is uniform to obtain precursor solution A. Hydrothermally react the precursor solution A at 160 ° C for 12 h, with a filling rate of 80%. Finally, collect the precipitate in the reaction solution in turn, wash it with deionized water and anhydrous ethanol for 3 times, dry it and grind it to obtain nano-flower spherical BiOBr powder;

[0082] Step 2: Disperse 0.25 mmol of nanoflower spherical BiOBr powder and 0.125 mmol of sodium iodate in 40 mL of deionized water, and then stir for 30 min to obtain precursor solution B;

[0083] Step 3: The precursor solution B was transferred to a hydrothermal reactor for hydrothermal reaction at 150°C for 6 hours with a filling rate of 80%. After the reaction was completed, the precipitate was washed 3 times with deionized water and anhydrous ethanol respectively, dried at 70°C for 12 hours and then ground to obtain BiOBr / BiOIO3 photocatalyst.

[0084] Example 7

[0085] Step 1: Dissolve 1 mmol of bismuth nitrate pentahydrate and 1 mmol of sodium bromide in 40 mL of deionized water, and then stir for 30 min until the solution is uniform to obtain precursor solution A. Hydrothermally react the precursor solution A at 160 ° C for 12 h, with a filling rate of 80%. Finally, collect the precipitate in the reaction solution in turn, wash it with deionized water and anhydrous ethanol for 3 times, dry it and grind it to obtain nano-flower spherical BiOBr powder;

[0086] Step 2: Disperse 2 mmol of nanoflower spherical BiOBr powder and 1 mmol of sodium iodate in 40 mL of deionized water, and then stir for 30 min to obtain precursor solution B;

[0087] Step 3: The precursor solution B was transferred to a hydrothermal reactor for hydrothermal reaction at 150°C for 6 hours with a filling rate of 80%. After the reaction was completed, the precipitate was washed 3 times with deionized water and anhydrous ethanol respectively, dried at 70°C for 12 hours and then ground to obtain BiOBr / BiOIO3 photocatalyst.

[0088] Example 8

[0089] Step 1: Dissolve 1 mmol of bismuth nitrate pentahydrate and 1 mmol of sodium bromide in 40 mL of deionized water, and then stir for 30 min until the solution is uniform to obtain precursor solution A. Hydrothermally react the precursor solution A at 160 ° C for 12 h, with a filling rate of 80%. Finally, collect the precipitate in the reaction solution in turn, wash it with deionized water and anhydrous ethanol for 3 times, dry it and grind it to obtain nano-flower spherical BiOBr powder;

[0090] Step 2: Disperse 1 mmol of nanoflower spherical BiOBr powder and 0.5 mmol of sodium iodate in 40 mL of deionized water, and then stir for 30 min to obtain precursor solution B;

[0091] Step 3: The precursor solution B was transferred to a hydrothermal reactor for hydrothermal reaction at 140°C for 6 hours with a filling rate of 80%. After the reaction was completed, the precipitate was washed 3 times with deionized water and anhydrous ethanol respectively, dried at 70°C for 12 hours and then ground to obtain BiOBr / BiOIO3 photocatalyst.

[0092] Example 9

[0093] Step 1: Dissolve 1 mmol of bismuth nitrate pentahydrate and 1 mmol of sodium bromide in 40 mL of deionized water, and then stir for 30 min until the solution is uniform to obtain precursor solution A. Hydrothermally react the precursor solution A at 160 ° C for 12 h, with a filling rate of 80%. Finally, collect the precipitate in the reaction solution in turn, wash it with deionized water and anhydrous ethanol for 3 times, dry it and grind it to obtain nano-flower spherical BiOBr powder;

[0094] Step 2: Disperse 1 mmol of nanoflower spherical BiOBr powder and 0.5 mmol of sodium iodate in 40 mL of deionized water, and then stir for 30 min to obtain precursor solution B;

[0095] Step 3: The precursor solution B was transferred to a hydrothermal reactor and subjected to a hydrothermal reaction at 200°C for 6 hours with a filling rate of 80%. After the reaction was completed, the precipitate was washed three times with deionized water and anhydrous ethanol respectively, dried at 70°C for 12 hours and then ground to obtain a BiOBr / BiOIO3 photocatalyst.

[0096] Example 10

[0097] Step 1: Dissolve 1 mmol of bismuth nitrate pentahydrate and 1 mmol of sodium bromide in 40 mL of deionized water, and then stir for 30 min until the solution is uniform to obtain precursor solution A. Hydrothermally react the precursor solution A at 160 ° C for 12 h, with a filling rate of 80%. Finally, collect the precipitate in the reaction solution in turn, wash it with deionized water and anhydrous ethanol for 3 times, dry it and grind it to obtain nano-flower spherical BiOBr powder;

[0098] Step 2: Disperse 1 mmol of nanoflower spherical BiOBr powder and 0.5 mmol of sodium iodate in 40 mL of deionized water, and then stir for 30 min to obtain precursor solution B;

[0099] Step 3: The precursor solution B was transferred to a hydrothermal reactor for hydrothermal reaction at 150°C for 5 hours with a filling rate of 80%. After the reaction was completed, the precipitate was washed 3 times with deionized water and anhydrous ethanol respectively, dried at 70°C for 12 hours and then ground to obtain BiOBr / BiOIO3 photocatalyst.

[0100] Embodiment 11

[0101] Step 1: Dissolve 1mmol Bi(NO3)3·5H2O and 1mmol sodium bromide in 40mL deionized water, and then stir for 30min until the solution is uniform to obtain precursor solution A, and hydrothermally react the precursor solution A at 160°C for 12h with a filling rate of 80%. Finally, collect the precipitate in the reaction solution in turn, wash it with deionized water and anhydrous ethanol for 3 times, dry it and grind it to obtain nano-flower spherical BiOBr powder;

[0102] Step 2: Disperse 1 mmol of nanoflower spherical BiOBr powder and 0.5 mmol of sodium iodate in 40 mL of deionized water, and then stir for 30 min to obtain precursor solution B;

[0103] Step 3: The precursor solution B was transferred to a hydrothermal reactor for hydrothermal reaction at 150°C for 7 hours with a filling rate of 80%. After the reaction was completed, the precipitate was washed 3 times with deionized water and anhydrous ethanol respectively, dried at 70°C for 12 hours and then ground to obtain BiOBr / BiOIO3 photocatalyst.

[0104] Example 12

[0105] Step 1: Dissolve 1mmol Bi(NO3)3·5H2O and 1mmol sodium bromide in 40mL deionized water, and then stir for 30min until the solution is uniform to obtain precursor solution A, and hydrothermally react the precursor solution A at 160°C for 12h with a filling rate of 80%. Finally, collect the precipitate in the reaction solution in turn, wash it with deionized water and anhydrous ethanol for 3 times, dry it and grind it to obtain nano-flower spherical BiOBr powder;

[0106] Step 2: Disperse 1 mmol of nanoflower spherical BiOBr powder and 0.5 mmol of sodium iodate in 40 mL of deionized water, and then stir for 30 min to obtain precursor solution B;

[0107] Step 3: The precursor solution B was transferred to a hydrothermal reactor for hydrothermal reaction at 150°C for 8 hours with a filling rate of 80%. After the reaction was completed, the precipitate was washed 3 times with deionized water and anhydrous ethanol respectively, dried at 70°C for 12 hours and then ground to obtain BiOBr / BiOIO3 photocatalyst.

[0108] Figure 1: This is the XRD diagram of the photocatalyst prepared by the present invention, in which a corresponds to the powder prepared in Example 1, be corresponds to Examples 1-4, and f corresponds to the powder prepared in Example 2. The diffraction peaks at 2θ=10.9°, 21.93°, 25.16°, 31.69°, and 32.22° in Examples 1-4 correspond to the (001), (002), (101), (102), and (110) crystal planes of the tetragonal phase BiOBr (JCPDS No. 41-1488), respectively, and the space group is P4 / nmm(129); the diffraction peaks at 2θ=27.36°, 31.11°, 31.61°, 32.46°, and 32.96° correspond to the orthorhombic system BiOIO3 (JCPDS No.26-2019), proving the coexistence of BiOBr and BiOIO3 phases. Moreover, with the increase of NaIO3, the diffraction peak of BiOIO3 appeared and gradually strengthened, confirming the successful preparation of BiOBr / BiOIO3 photocatalyst.

[0109] When NaIO3 and BiOBr are added to water, NaIO3 will hydrolyze into Na + and io3 - (Reaction (1)), and the BiOBr on the surface of BiOBr in aqueous solution will hydrolyze to form BiO + and Br - (Reaction formula (2)) BiOBr·BiO is formed on the surface of BiOBr. + The colloid particles (reaction (3)) are positively charged and then adsorb IO3 in the solution. - Br - and OH - , forming a diffuse double layer, IO3 - More polar than Br - , forming micelle BiOBr·BiO·IO3 (reaction (4)), under the action of hydrothermal high temperature and high pressure, micelle forms BiOBr / BiOIO3 (reaction (5)), due to the existence of diffuse double layer, between BiOBr and [BiO·IO3] at the solid-liquid interface of micelle, [BiO·IO3] forms a wrapped structure on the surface of BiOBr, crystallizes to form core-shell structure BiOBr@BiOIO3, and at the solid-liquid interface of micelle BiOBr and BiO + The interfacial electric field is formed between them, with the direction of BiOIO3 pointing to BiOBr. Under the action of the interfacial electric field, the electrons in BiOBr migrate to BiOIO3, reducing part of IO3 - For I3 - ,I - , hydrothermal formation of BiOBr / BiO(IO3) 1-x-y (I3) x Iy Z-type heterojunction.

[0110]

[0111] BiOBr+H2O→BiO + +Br - (2)

[0113] BiOBr+BiO + +H2O=BiOBr·BiO + +H2O (3)

[0114]

[0115]

[0116] Figure 2 This is the Raman image of the photocatalyst prepared by the present invention, in which a corresponds to Example 1, be corresponds to Examples 1-4, and f corresponds to the powder prepared by Example 2. -1 The strong Raman peak at 1g Internal Bi-O stretching mode, 161.681 cm -1 The Raman peak at is attributed to BiOBr E g Internal Bi-O stretching mode, with [Bi2O2] 2+ Layers and dihalides [Br2] 2- The compression movement of the layer is related to the -1 The strong Raman peak at 116 cm-1 is attributed to the IO stretching mode of BiOIO3. -1 and 161.681cm -1 A 1g and E g The mold strength gradually weakens at 650-800cm -1 The BiOIO3 IO stretching mode at the site gradually increases, indicating that the BiOIO3 content in the BiOBr / BiOIO3 photocatalyst increases.

[0117] Figure 3 This is the XPS full spectrum of the BiOBr / BiOIO3 photocatalyst prepared in Comparative Example 1, Comparative Example 2 and Example 2 of the present invention. In the figure, a, c, and f are powders prepared according to Comparative Example 1, Example 2 and Comparative Example 2, respectively, indicating that the BiOBr / BiOIO3 photocatalyst is mainly composed of Bi, O, Br, and I elements, which is consistent with the XRD results.

[0118] Figure 4The high-resolution O 1s XPS spectra of the BiOBr / BiOIO3 photocatalysts prepared in Comparative Example 1, Comparative Example 2 and Example 2 of the present invention are shown in Figure 1. The O 1s spectrum of BiOBr in Comparative Example 1 can be fitted into two peaks, with the peaks at 532.52 eV and 530.25 eV corresponding to oxygen vacancies and [Bi2O2], respectively. 2+ The lattice oxygen atoms of the layer have an oxygen vacancy concentration of about 10.44%. The BiOIO3 O 1s spectrum of Comparative Example 2 can be fitted into three peaks, and the peaks at 531.94 eV, 529.51 eV, and 527.24 eV correspond to oxygen vacancies, [Bi2O2] 2+ The lattice oxygen atoms of the layer, IO3 - The lattice oxygen atoms in the BiOBr / BiOIO3 have an oxygen vacancy concentration of about 5.67%. The O 1s spectrum of BiOBr / BiOIO3 can be fitted into three peaks, with the peaks at 531.83 eV, 529.37 eV, and 527.27 eV corresponding to oxygen vacancies, [Bi2O2] 2+ The lattice oxygen atoms of the layer, IO3 - The lattice oxygen atoms in the BiOBr / BiOIO3 have an oxygen vacancy concentration of about 11.96%. Compared with BiOBr and BiOIO3 in Comparative Examples 1 and 2, the oxygen vacancy concentration increases, and the binding energy shifts to the right, proving that the charge density of O in BiOBr / BiOIO3 increases.

[0119] Figure 5 The high-resolution Bi 4f XPS spectra of the photocatalysts prepared in Comparative Example 1, Comparative Example 2 and Example 2 of the present invention are shown. The BiOBr of Comparative Example 1 shows two strong peaks at about 164 eV and 158 eV, which are respectively attributed to Bi 3+ 4f 7 / 2 and Bi 3+ 4f 5 / 2, after fitting, it can be divided into 4 binding energies of 164.33eV, 158.98eV, 163.20eV and 157.78eV, 164.33eV and 158.98eV are attributed to Bi 3+ ,Bi 3+ The concentration is about 53.36%, and the low binding energies at 163.20 eV and 157.78 eV should be attributed to the low-charge Bi ions (Bi +(3-x) ), Bi +(3-x) The concentration is about 46.64%. In the BiOBr / BiOIO3 heterojunction, the peaks at 163.08eV and 157.71eV are attributed to Bi 3+ ,Bi 3+ The concentration is about 50.07%, and the peaks at 161.70eV and 156.15eV are attributed to Bi +(3-x) ,Bi +(3-x)The concentration is about 49.93%, and the binding energy shifts to the right, proving that the interface interaction between BiOBr / BiOIO3 causes the change of Bi chemical environment. The BiOIO3 of comparative example 2 can also be fitted into 163.35 and 158.52 eV (Bi 3+ , concentration is about 47.17%), 161.96 and 157.12eV (Bi +(3-x) , concentration is about 52.83%), indicating that the Bi ions in the catalysts prepared in Comparative Example 1, Comparative Example 2 and Example 2 exist Bi 3+ and Bi +(3-x) .Bi 3+ and Bi +(3-x) The formation of OVs is related to the weak Bi-O bond and long bond length, which makes it easy to break. When an internal O atom is removed from the lattice, OVs is formed, leaving a Bi dangling bond and two electrons. Due to charge compensation, the remaining electrons are bonded to Bi 3+ Combine to form a low-price Bi 3+ (i.e. Bi +(3-x) ). This indicates that when BiOBr / BiOIO3 is formed, due to the existence of a diffuse double electric layer, an interfacial electric field pointing from BiOIO3 to BiOBr is formed at the solid-liquid interface of the colloid particles. BiOBr forms OVs due to the hydrothermal anoxic environment. Under the action of the built-in electric field of the interface, the bound electrons of BiOBr migrate to BiOIO3, making the Bi of BiOBr in BiOBr / BiOIO3 3+ As the concentration increases, the Bi +(3-x) The concentration increases until the Fermi levels of the two reach equilibrium, forming a BiOBr / BiOIO3 heterojunction.

[0120] Figure 6 The high-resolution I 3d XPS spectra of the BiOBr / BiOIO3 photocatalysts prepared in Comparative Example 2 and Example 2 of the present invention are shown in FIG. The BiOIO3 in Comparative Example 2 shows two characteristic peaks at 630 eV and 618 eV, corresponding to I 3d 5 / 2 and I3d 3 / 2, respectively. After fitting, the peaks are divided into six binding energy peaks at 630.63 eV and 619.16 eV, 629.11 eV and 617.63 eV, 626.75 eV and 615.69 eV, and 630.63 eV and 619.16 eV correspond to I 3d 5 / 2 and I3d 3 / 2, respectively. 5+ , 629.11, 617.63 eV correspond to I3 - , 626.75, 615.69 eV correspond to I - , so the I ion exists in I 5+ / I3 - / I - , I 5+ 、I3 - ,I -The concentrations are 44.72%, 40.52%, and 14.76%, respectively. 630.36eV ​​and 618.94eV in BiOBr / BiOIO3 correspond to I 5+ , 628.85, 617.32eV correspond to I3 - , 625.63, 614.96 eV correspond to I - , I 5+ 、I3 - ,I - The concentrations are 42.67%, 41.10%, and 16.23%, respectively. Therefore, I 5+ / I3 - / I - , I 5+ / I3 - / I - The formation of OVs is related to the residual electrons after the formation of OVs (reaction (6)), which leads to IO3 - Restored to I3 - / I - (Reaction formula (7), reaction formula (8)) 5+ 、I3 - ,I - The concentration change is also related to the electrons in BiOBr migrating to BiOIO3 under the action of the interfacial electric field, reducing IO3 - For I3 - ,I - Therefore, the prepared BiOBr / BiOIO3 photocatalyst is BiOBr / BiO(IO3) 1-x-y (I3) x I y (Reaction (9)). The binding energy of I 3d in BiOBr / BiOIO3 shifts to the right, and I3 - / I - The increase in concentration proves the existence of the built-in electric field on the interface, which causes the electrons bound to BiOBr to migrate to BiOIO3 under the action of the built-in electric field on the interface.

[0121]

[0122]

[0123]

[0124] BiOBr / BiOIO3+ne - →BiOBr / BiO(IO3) 1-x-y (I3) x I y (9)

[0125] Figure 7 The UV-visible diffuse reflectance spectrum of the photocatalyst prepared by the present invention is shown in Figure 1, where a corresponds to Example 1, be corresponds to Examples 1-4, and f corresponds to the powder prepared by Example 2. BiOBr has typical semiconductor absorption in the visible light wavelength range, and its absorption edge is approximately at 438nm. BiOIO3 has a large bandgap and responds to ultraviolet light, but due to I3 - and I - The absorption edge of BiOBr / BiOIO3 photocatalyst is located at about 550nm due to the presence of Bi 3+ / Bi +(3-x) Ion Pairs and IO3 - / I3 - / I - ions exist, and visible light absorption is exhibited in the range of 200-800nm, and its optical properties are further improved compared with BiOBr and BiOIO3.

[0126] Figure 8 : is the removal curve of 20 mg / L tetracycline by the catalyst powder prepared by the present invention under visible light irradiation, a corresponds to the powder prepared in Example 1, be corresponds to Examples 1-4, and f corresponds to the powder prepared in Example 2. Fig. 9 is the corresponding apparent rate constant, and the C / C0 on the ordinate is the ratio of the concentration of tetracycline after degradation to its initial concentration. It can be seen from the figure that after 80 minutes of visible light irradiation, the degradation rates of tetracycline by the photocatalysts prepared in Comparative Example 1, Examples 1-4 and Comparative Example 2 were 38.22%, 54.53%, 57.57%, 53.03%, 38.94% and 40.14%, respectively, and the corresponding apparent rate constants were 0.00465, 0.00624, 0.00656, 0.00574, 0.00338 and 0.00233min, respectively. -1 It can be seen that the prepared BiOBr / BiOIO3 photocatalyst exhibits significantly higher photocatalytic performance than pure BiOBr and BiOIO3 catalysts.

[0127] Fig.10 : is the removal curve of 20 mg / L tetracycline by the catalyst powder prepared by the present invention under near-infrared light irradiation, a corresponds to the powder prepared in Example 1, be corresponds to Examples 1-4, and f corresponds to the powder prepared in Example 2. Fig.11is the corresponding apparent rate constant, and the C / C0 on the ordinate is the ratio of the concentration of tetracycline after degradation to its initial concentration. It can be seen from the figure that after 200 minutes of near-infrared light irradiation, the degradation efficiency of tetracycline by the BiOBr / BiOIO3 photocatalysts prepared in Comparative Example 1, Examples 1-4 and Comparative Example 2 were 27.33%, 42.32%, 34.3%, 38.53%, 35.78% and 32.08%, respectively, and the corresponding apparent rate constants were 0.00047, 0.0013, 0.0015, 0.00111, 0.00111 and 0.00137min, respectively. -1 It can be seen that the prepared BiOBr / BiOIO3 photocatalyst exhibits significantly higher photocatalytic performance than pure BiOBr and BiOIO3 catalysts. Regardless of visible light or near-infrared light, the BiOBr / BiOIO3 photocatalyst has a higher degradation rate and degradation rate, and can more effectively utilize solar energy.

[0128] Fig.12 This is a graph of the degradation of 10 mg / L bisphenol A and 10 mg / L ciprofloxacin by the BiOBr / BiOIO3 photocatalyst prepared in Example 2 of the present invention under visible light and near-infrared light. As can be seen from the figure, under visible light, the degradation rates of bisphenol A and ciprofloxacin by the BiOBr / BiOIO3 photocatalyst are 59.12% and 55.01% respectively, and under near-infrared light, the degradation rates of bisphenol A and ciprofloxacin by the BiOBr / BiOIO3 photocatalyst are 36.12% and 39.54% respectively. The prepared BiOBr / BiOIO3 photocatalyst has universal applicability and also has good degradation ability for other antibiotics and organic matter.

[0129] Fig.13 The band gap diagrams of BiOBr and BiOIO3 photocatalysts prepared in Comparative Examples 1 and 2 of the present invention are shown in Table 1. According to the Kubelka-Munk formula: αhν=A(hν-Eg) n / 2 Calculate the band gap energy of the sample, where α, h, ν and E g Represent the light absorption coefficient, Planck constant, incident light frequency and band gap energy respectively, A is a constant, and the n value is related to the light conversion type of the semiconductor material. BiOBr and BiOIO3 are both indirect transition semiconductors, and the n value is 4. The band gap energies of BiOBr and BiOIO3 are 2.69eV and 2.90eV respectively.

[0130] Fig.14 is the XPS VB graph of the BiOBr photocatalyst prepared in Comparative Example 1 of the present invention, Fig.15This is the XPS VB diagram of the BiOIO3 photocatalyst prepared in Comparative Example 2 of the present invention. It can be obtained that the valence band potentials of BiOBr and BiOIO3 are +2.59eV and +3.19eV respectively. According to the formula: E CB =E VB -E g The calculated conduction band potentials of BiOBr and BiOIO3 are -0.1eV and +0.29eV, respectively.

[0131] Fig.16 This is a detection diagram of active species of tetracycline degradation under visible light by BiOBr / BiOIO3 catalyst prepared in Example 2 of the present invention. p-Benzoquinone, sodium oxalate and tert-butyl alcohol were introduced as O2 - ,h + and ·OH capture agent. According to the capture results, ·O2 - and h + It is the main active species. Since the conduction band position of BiOBr is more negative than that of BiOIO3, and the valence band position of BiOIO3 is more positive than that of BiOBr, the photogenerated electrons of BiOBr tend to migrate to the conduction band position of BiOIO3, while the photogenerated holes of BiOIO3 tend to migrate to the valence band position of BiOBr. However, the conduction band potential of BiOIO3 is lower than that of O2 / ·O2 - In this case, the photogenerated electrons cannot generate O2 through the reduction reaction. - The free radicals participate in the photocatalytic reaction, which is contrary to the results of the active species capture experiment. Therefore, the photocatalytic mechanism cannot follow the type II mechanism.

[0132] Fig.17 The photocatalytic mechanism diagram of the BiOBr / BiOIO3 heterojunction photocatalyst prepared by the present invention is shown. According to the active species capture experiment, the prepared BiOBr / BiOIO3 heterojunction should follow the Z-type charge transfer path. Due to the presence of a diffuse double electric layer in the solution, a core-shell structure BiOBr@BiOIO3 is formed, and an interfacial electric field is formed between BiOBr and BiOIO3 at the colloid solid-liquid interface, with the direction of BiOIO3 pointing to BiOBr. At the same time, since the work function of BiOBr (5.91eV) is smaller than that of BiOIO3 (6.69eV), when the two semiconductors are in contact, due to the Fermi level (E f ), the free carriers in BiOBr will spontaneously transfer to BiOIO3 until their E f Aligned at the same level, therefore, the Fermi level and band structure of BiOBr and BiOIO3 decrease and increase, respectively, forming a BiOBr / BiOIO3 Z-type heterojunction, and the conduction band and valence band potentials of BiOIO3 are increased to -0.20 eV and +2.70 eV.

[0133] Under visible light, Bi 3+ / Bi +(3-x) The energy level is lower than the conduction band of BiOBr, I3 - / I - (0.54eV) and IO3 - / I - (1.09eV) is higher than the valence band of BiOIO3. When excited by visible light, electrons and holes can quickly migrate to the conduction band and valence band of BiOBr and BiOIO3 respectively through the impurity energy level. Under the action of the built-in electric field at the interface, the electrons in the conduction band of BiOBr recombine with the holes in the valence band of BiOIO3, retaining the conduction band electrons with strong reducing ability of BiOIO3 and the holes in the valence band of BiOBr with strong oxidizing ability, thereby degrading antibiotics and bisphenol A.

[0134] Under near-infrared irradiation, IO3 in BiOIO3 - / I3 - / I - The photoexcited state is in a dynamic cycle (reaction equations (10) to (12)), forming active species·O2 - , ·OH, 1 O2 reacts with antibiotics (reactions (13) to (15)), and due to Bi 3+ / Bi +(3-x) The bound electrons formed in BiOBr generate high-energy hot electrons under the excitation of infrared, and the hot electrons react with dissolved oxygen to form O2 - Participate in the degradation of antibiotics and bisphenol A. 3-x-y (I3) x I y Bi exists in the heterojunction 3+ / Bi +(3-x) and io3 - / I3 - / I - Defect pairs, when irradiated by near-infrared radiation, electrons and holes can also quickly migrate to the conduction band and valence band of BiOBr and BiOIO3 through the impurity energy levels, and degrade antibiotics and bisphenol A according to the Z-type mechanism.

[0135]

[0136]

[0137]

[0138]

[0139]

[0140]

[0141] The present invention forms a Z-type BiOBr / BiOIO3 heterojunction by combining BiOBr and BiOIO3, and builds in an interface electric field, an LSPR effect of ion defect pairs and IO3 - / I3 - / I - Under the action of multiple active species formed by dynamic circulation, the degradation ability of heterojunction photocatalyst on antibiotics and bisphenol A under visible light and near-infrared light is enhanced. The method has a simple process and simple operation. The prepared Z-type BiOBr / BiOIO3 heterojunction photocatalyst has good application prospects in purifying water pollution.

[0142] The above is only one embodiment of the present invention, not all or the only embodiment. Any equivalent changes made to the technical solution of the present invention by ordinary technicians in this field after reading the specification of the present invention are covered by the claims of the present invention.

Claims

1. A BiOBr / BiOIO 3 Method for preparing photocatalyst, It is characterized in that The following steps are involved: Step 1: dissolving bismuth nitrate pentahydrate and sodium bromide in water to obtain a precursor solution A, subjecting the precursor solution A to a hydrothermal reaction, washing and drying the obtained solid product to obtain a nano-flower-shaped BiOBr powder; Step 2: Dispersing nanoflower-shaped BiOBr powder and sodium iodate in water to obtain precursor solution B; Step 3: The precursor solution B is subjected to a hydrothermal reaction, and the resulting precipitate is washed and dried to obtain BiOBr / BiOIO 3 Photocatalyst.

2. BiOBr / BiOIO according to claim 1 3 Method for preparing photocatalyst, It is characterized in that In step 1, the molar ratio of bismuth nitrate pentahydrate to sodium bromide is 1:

1.

3. The BiOBr / BiOIO according to claim 1 3 Method for preparing photocatalyst, It is characterized in that In step 1, the temperature of the hydrothermal reaction is 160° C. and the time is 12 h.

4. The BiOBr / BiOIO according to claim 1 3 A method for preparing a photocatalyst, It is characterized in that In step 2, the molar ratio of the nano-flower-shaped BiOBr powder to sodium iodate in the precursor solution B is (0.25-2): (0.125-1).

5. The BiOBr / BiOIO according to claim 1 3 A method for preparing a photocatalyst, It is characterized in that In step 2, in the precursor solution B, BiOBr and NaIO 3 The concentrations were (0.00625-0.05) mol / L and (0.003125-0.0375) mol / L respectively.

6. The BiOBr / BiOIO according to claim 1 3 Method for preparing photocatalyst, It is characterized in that In step 3, the temperature of the hydrothermal reaction is 140-200° C. and the time is 5-8 hours.

7. A BiOBr / BiOIO 3 Photocatalysts, It is characterized in that The BiOBr / BiOIO 3 BiOBr and BiOIO in photocatalysts 3 Two phases coexist, BiOBr and BiOIO 3 A Z-type heterojunction is formed.

8. The BiOBr / BiOIO of claim 7 3 The application of photocatalysts in catalytic degradation of antibiotics or bisphenol A under light conditions.

9. The use according to claim 8, It is characterized in that The antibiotics were tetracycline or ciprofloxacin.

10. The use according to claim 8, It is characterized in that The lighting condition is infrared light irradiation, visible light irradiation or sunlight irradiation.